Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth
NCT00006135Phase 3Completed
- Sponsor
- National Center for Research Resources
- Start
- Jun 1997
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in herpes simplex virus infection comparing Oral Acyclovir with Placebo (2 arms). Primary endpoints: Efficacy of suppressive therapy at 6 months, Neurologic outcome at 60 months and 2 more. Started Jun 1997; status: completed.
02
Drugs
aciclovir
03
Conditions
herpes simplex virus infection
Beyond the preview
Go deeper on NCT00006135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006135.